Liraglutide, analog of human GLP-1 with prolonged half-life having a fatty acid palmitoyl group conjugated to the side-chain of Lys26 and an Arg34Ser substitution, is now widely used in T2DM therapy [67]. Here, GLP1R is linked to type 2 diabetes mellitus.